Author:
Lanini Simone,Molloy Aoife C,Prentice Archibald G,Ippolito Giuseppe,Kibbler Christopher C
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Leandro MJ, Cooper N, Cambridge G, Ehrenstein MR, Edwards JC: Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy. Rheumatology (Oxford). 2007, 46 (1): 29-36. 10.1093/rheumatology/kel148.
2. Baz R, Fanning S, Kunkel L, Gaballa S, Karam MA, Reed J, Kelly M, Hussein M: Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myeloma. Leuk Lymphoma. 2007, 48 (12): 2338-44. 10.1080/10428190701644330.
3. Schulz H, Bohlius J, Skoetz N, Trelle S, Kober T, Reiser M, Dreyling M, Herold M, Schwarzer G, Hallek M, Engert A: Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. Cochrane Db Syst Rev. 2007, 4: CD003805-
4. Lanini S, Molloy AC, Fine PE, Prentice AG, Ippolito G, Kibbler CC: Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis. BMC Med. 2011, 9: 36-10.1186/1741-7015-9-36.
5. European Medicines Agency (EMEA): MabThera EMEA/H/C/000165 -II/0070/G 20/12/2010 available at
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000165/human_med_000897.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d125
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献